HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanuel Feroldi Selected Research

Vaccines

12/2020Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France.
1/2019Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
1/2018Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
1/2018Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
11/2017A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
1/2017Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.
1/2017Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
1/2017A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3-, 5- and 11- to 12-month Schedule.
11/2016Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
9/2014Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanuel Feroldi Research Topics

Disease

13Japanese Encephalitis
01/2019 - 11/2010
5Tetanus
01/2019 - 03/2008
5Whooping Cough (Pertussis)
01/2019 - 03/2008
5Diphtheria
01/2019 - 03/2008
5Hepatitis B
01/2019 - 01/2017
4Poliomyelitis (Polio)
11/2017 - 03/2008
3Hepatitis A (Hepatitis, Infectious)
11/2016 - 12/2010
1Communicable Diseases (Infectious Diseases)
12/2020
1Injection Site Reaction
12/2020
1Infections
01/2019
1Mumps
09/2014
1Measles
09/2014
1Rubella (German Measles)
09/2014
1Yellow Fever
11/2010
1Rabies (Hydrophobia)
02/2009

Drug/Important Bio-Agent (IBA)

18VaccinesIBA
12/2020 - 03/2008
5Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)IBA
01/2019 - 01/2017
2Phosphates (Orthophosphate)IBA
01/2019 - 01/2017
2AntigensIBA
01/2017 - 02/2009
2Rabies Vaccines (Rabies Vaccine)FDA Link
02/2009 - 03/2008
1Neutralizing AntibodiesIBA
01/2019
1AntipyreticsIBA
11/2017
1Hemagglutinins (Hemagglutinin)IBA
01/2017
1Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link
01/2017
1hemoglobins NIBA
01/2017
1Pertussis ToxinIBA
01/2017
1Formaldehyde (Formol)FDA Link
11/2016
1Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA
09/2014
1AntibodiesIBA
03/2014
1Attenuated VaccinesIBA
11/2010
1Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link
11/2010
1Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA
02/2009

Therapy/Procedure

1Intradermal Injections
03/2008